News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Krishnamohan Neha
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/05/2023 |
4
| Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Paid exercise price by delivering 1,459 shares
@ $4.3, valued at
$6.3k
|
|
| 06/02/2023 |
4
| Krishnamohan Neha (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 02/14/2023 |
4
| Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 215,000 options to buy
@ $6.78, valued at
$1.5M
|
|
| 12/02/2022 |
4
| Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Paid exercise price by delivering 1,459 shares
@ $7.75, valued at
$11.3k
|
|
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Krishnamohan Neha (CFO) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 185,000 options to buy
@ $10.03, valued at
$1.9M
|
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|